Position in ENTX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$33,868
+$12,629 QoQ
Shares Held
19,135
0.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#19
of 27 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Gem Investment Advisors, LLC holds $54,680,183 across 7 Biotechnology names. ENTX ranks #7 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABSI |
Absci Corp
|
2,170,863 | $25,160,302 | |
| 2 | DRTS |
Alpha Tau Medical Ltd.
|
1,434,476 | $18,045,708 | |
| 3 | ORMP |
Oramed Pharmaceuticals Inc.
|
1,998,802 | $9,614,237 | |
| 4 | LRMR |
Larimar Therapeutics, Inc.
|
319,519 | $974,532 | |
| 5 | ABEO |
Abeona Therapeutics Inc.
|
99,084 | $612,339 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
13,747 | $239,197 | |
| 7 | ENTX |
Entera Bio Ltd.
This page
|
19,135 | $33,868 |
All Filings in ENTX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,868 | 19,135 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $21,239 | 19,135 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $37,121 | 19,135 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||